

<!DOCTYPE html>


<html lang="en" >

  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" /><meta name="generator" content="Docutils 0.18.1: http://docutils.sourceforge.net/" />

    <title>Bar Chart &#8212; Data Expressions</title>
  
  
  
  <script data-cfasync="false">
    document.documentElement.dataset.mode = localStorage.getItem("mode") || "";
    document.documentElement.dataset.theme = localStorage.getItem("theme") || "light";
  </script>
  
  <!-- Loaded before other Sphinx assets -->
  <link href="../_static/styles/theme.css?digest=e353d410970836974a52" rel="stylesheet" />
<link href="../_static/styles/bootstrap.css?digest=e353d410970836974a52" rel="stylesheet" />
<link href="../_static/styles/pydata-sphinx-theme.css?digest=e353d410970836974a52" rel="stylesheet" />

  
  <link href="../_static/vendor/fontawesome/6.1.2/css/all.min.css?digest=e353d410970836974a52" rel="stylesheet" />
  <link rel="preload" as="font" type="font/woff2" crossorigin href="../_static/vendor/fontawesome/6.1.2/webfonts/fa-solid-900.woff2" />
<link rel="preload" as="font" type="font/woff2" crossorigin href="../_static/vendor/fontawesome/6.1.2/webfonts/fa-brands-400.woff2" />
<link rel="preload" as="font" type="font/woff2" crossorigin href="../_static/vendor/fontawesome/6.1.2/webfonts/fa-regular-400.woff2" />

    <link rel="stylesheet" type="text/css" href="../_static/pygments.css" />
    <link rel="stylesheet" href="../_static/styles/sphinx-book-theme.css?digest=14f4ca6b54d191a8c7657f6c759bf11a5fb86285" type="text/css" />
    <link rel="stylesheet" type="text/css" href="../_static/togglebutton.css" />
    <link rel="stylesheet" type="text/css" href="../_static/copybutton.css" />
    <link rel="stylesheet" type="text/css" href="../_static/mystnb.4510f1fc1dee50b3e5859aac5469c37c29e427902b24a333a5f9fcb2f0b3ac41.css" />
    <link rel="stylesheet" type="text/css" href="../_static/sphinx-thebe.css" />
    <link rel="stylesheet" type="text/css" href="../_static/design-style.4045f2051d55cab465a707391d5b2007.min.css" />
  
  <!-- Pre-loaded scripts that we'll load fully later -->
  <link rel="preload" as="script" href="../_static/scripts/bootstrap.js?digest=e353d410970836974a52" />
<link rel="preload" as="script" href="../_static/scripts/pydata-sphinx-theme.js?digest=e353d410970836974a52" />

    <script data-url_root="../" id="documentation_options" src="../_static/documentation_options.js"></script>
    <script src="../_static/jquery.js"></script>
    <script src="../_static/underscore.js"></script>
    <script src="../_static/_sphinx_javascript_frameworks_compat.js"></script>
    <script src="../_static/doctools.js"></script>
    <script src="../_static/clipboard.min.js"></script>
    <script src="../_static/copybutton.js"></script>
    <script src="../_static/scripts/sphinx-book-theme.js?digest=5a5c038af52cf7bc1a1ec88eea08e6366ee68824"></script>
    <script>let toggleHintShow = 'Click to show';</script>
    <script>let toggleHintHide = 'Click to hide';</script>
    <script>let toggleOpenOnPrint = 'true';</script>
    <script src="../_static/togglebutton.js"></script>
    <script>var togglebuttonSelector = '.toggle, .admonition.dropdown';</script>
    <script src="../_static/design-tabs.js"></script>
    <script>const THEBE_JS_URL = "https://unpkg.com/thebe@0.8.2/lib/index.js"
const thebe_selector = ".thebe,.cell"
const thebe_selector_input = "pre"
const thebe_selector_output = ".output, .cell_output"
</script>
    <script async="async" src="../_static/sphinx-thebe.js"></script>
    <script>DOCUMENTATION_OPTIONS.pagename = 'step-by-step/altair-1-bar-chart';</script>
    <link rel="index" title="Index" href="../genindex.html" />
    <link rel="search" title="Search" href="../search.html" />
    <link rel="next" title="Scatter Chart" href="altair-2-scatter-chart.html" />
    <link rel="prev" title="Altair" href="step-by-step-altair.html" />
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <meta name="docsearch:language" content="en"/>
  </head>
  
  
  <body data-bs-spy="scroll" data-bs-target=".bd-toc-nav" data-offset="180" data-bs-root-margin="0px 0px -60%" data-default-mode="">

  
  
  <a class="skip-link" href="#main-content">Skip to main content</a>
  
  <input type="checkbox"
          class="sidebar-toggle"
          name="__primary"
          id="__primary"/>
  <label class="overlay overlay-primary" for="__primary"></label>
  
  <input type="checkbox"
          class="sidebar-toggle"
          name="__secondary"
          id="__secondary"/>
  <label class="overlay overlay-secondary" for="__secondary"></label>
  
  <div class="search-button__wrapper">
    <div class="search-button__overlay"></div>
    <div class="search-button__search-container">
<form class="bd-search d-flex align-items-center"
      action="../search.html"
      method="get">
  <i class="fa-solid fa-magnifying-glass"></i>
  <input type="search"
         class="form-control"
         name="q"
         id="search-input"
         placeholder="Search this book..."
         aria-label="Search this book..."
         autocomplete="off"
         autocorrect="off"
         autocapitalize="off"
         spellcheck="false"/>
  <span class="search-button__kbd-shortcut"><kbd class="kbd-shortcut__modifier">Ctrl</kbd>+<kbd>K</kbd></span>
</form></div>
  </div>
  
    <nav class="bd-header navbar navbar-expand-lg bd-navbar">
    </nav>
  
  <div class="bd-container">
    <div class="bd-container__inner bd-page-width">
      
      <div class="bd-sidebar-primary bd-sidebar">
        

  
  <div class="sidebar-header-items sidebar-primary__section">
    
    
    
    
  </div>
  
    <div class="sidebar-primary-items__start sidebar-primary__section">
        <div class="sidebar-primary-item">
  

<a class="navbar-brand logo" href="../intro.html">
  
  
  
  
    
    
      
    
    
    <img src="../_static/data_expressions_logo.svg" class="logo__image only-light" alt="Logo image"/>
    <script>document.write(`<img src="../_static/data_expressions_logo.svg" class="logo__image only-dark" alt="Logo image"/>`);</script>
  
  
</a></div>
        <div class="sidebar-primary-item"><nav class="bd-links" id="bd-docs-nav" aria-label="Main">
    <div class="bd-toc-item navbar-nav active">
        
        <ul class="nav bd-sidenav bd-sidenav__home-link">
            <li class="toctree-l1">
                <a class="reference internal" href="../intro.html">
                    Intro
                </a>
            </li>
        </ul>
        <p aria-level="2" class="caption" role="heading"><span class="caption-text">Step-by-step Guides</span></p>
<ul class="current nav bd-sidenav">
<li class="toctree-l1 current active has-children"><a class="reference internal" href="step-by-step-altair.html">Altair</a><input checked="" class="toctree-checkbox" id="toctree-checkbox-1" name="toctree-checkbox-1" type="checkbox"/><label class="toctree-toggle" for="toctree-checkbox-1"><i class="fa-solid fa-chevron-down"></i></label><ul class="current">
<li class="toctree-l2 current active"><a class="current reference internal" href="#">Bar Chart</a></li>

<li class="toctree-l2"><a class="reference internal" href="altair-2-scatter-chart.html">Scatter Chart</a></li>
</ul>
</li>
<li class="toctree-l1 has-children"><a class="reference internal" href="step-by-step-plotly.html">Plotly</a><input class="toctree-checkbox" id="toctree-checkbox-2" name="toctree-checkbox-2" type="checkbox"/><label class="toctree-toggle" for="toctree-checkbox-2"><i class="fa-solid fa-chevron-down"></i></label><ul>
<li class="toctree-l2"><a class="reference internal" href="plotly-express.html">Plotly Express</a></li>

</ul>
</li>
</ul>
<p aria-level="2" class="caption" role="heading"><span class="caption-text">Data Poetry</span></p>
<ul class="nav bd-sidenav">
<li class="toctree-l1"><a class="reference internal" href="../data-poetry/polars.html">Polars dataframe</a></li>
</ul>
<p aria-level="2" class="caption" role="heading"><span class="caption-text">References</span></p>
<ul class="nav bd-sidenav">
<li class="toctree-l1"><a class="reference internal" href="../references.html">References</a></li>
</ul>

    </div>
</nav></div>
    </div>
  
  
  <div class="sidebar-primary-items__end sidebar-primary__section">
  </div>
  
  <div id="rtd-footer-container"></div>


      </div>
      
      <main id="main-content" class="bd-main">
        
        

<div class="sbt-scroll-pixel-helper"></div>

          <div class="bd-content">
            <div class="bd-article-container">
              
              <div class="bd-header-article">
<div class="header-article-items header-article__inner">
  
    <div class="header-article-items__start">
      
        <div class="header-article-item"><label class="sidebar-toggle primary-toggle btn btn-sm" for="__primary" title="Toggle primary sidebar" data-bs-placement="bottom" data-bs-toggle="tooltip">
  <span class="fa-solid fa-bars"></span>
</label></div>
      
    </div>
  
  
    <div class="header-article-items__end">
      
        <div class="header-article-item">

<div class="article-header-buttons">





<div class="dropdown dropdown-source-buttons">
  <button class="btn dropdown-toggle" type="button" data-bs-toggle="dropdown" aria-expanded="false" aria-label="Source repositories">
    <i class="fab fa-github"></i>
  </button>
  <ul class="dropdown-menu">
      
      
      
      <li><a href="https://github.com/executablebooks/jupyter-book" target="_blank"
   class="btn btn-sm btn-source-repository-button dropdown-item"
   title="Source repository"
   data-bs-placement="left" data-bs-toggle="tooltip"
>
  

<span class="btn__icon-container">
  <i class="fab fa-github"></i>
  </span>
<span class="btn__text-container">Repository</span>
</a>
</li>
      
      
      
      
      <li><a href="https://github.com/executablebooks/jupyter-book/issues/new?title=Issue%20on%20page%20%2Fstep-by-step/altair-1-bar-chart.html&body=Your%20issue%20content%20here." target="_blank"
   class="btn btn-sm btn-source-issues-button dropdown-item"
   title="Open an issue"
   data-bs-placement="left" data-bs-toggle="tooltip"
>
  

<span class="btn__icon-container">
  <i class="fas fa-lightbulb"></i>
  </span>
<span class="btn__text-container">Open issue</span>
</a>
</li>
      
  </ul>
</div>






<div class="dropdown dropdown-download-buttons">
  <button class="btn dropdown-toggle" type="button" data-bs-toggle="dropdown" aria-expanded="false" aria-label="Download this page">
    <i class="fas fa-download"></i>
  </button>
  <ul class="dropdown-menu">
      
      
      
      <li><a href="../_sources/step-by-step/altair-1-bar-chart.ipynb" target="_blank"
   class="btn btn-sm btn-download-source-button dropdown-item"
   title="Download source file"
   data-bs-placement="left" data-bs-toggle="tooltip"
>
  

<span class="btn__icon-container">
  <i class="fas fa-file"></i>
  </span>
<span class="btn__text-container">.ipynb</span>
</a>
</li>
      
      
      
      
      <li>
<button onclick="window.print()"
  class="btn btn-sm btn-download-pdf-button dropdown-item"
  title="Print to PDF"
  data-bs-placement="left" data-bs-toggle="tooltip"
>
  

<span class="btn__icon-container">
  <i class="fas fa-file-pdf"></i>
  </span>
<span class="btn__text-container">.pdf</span>
</button>
</li>
      
  </ul>
</div>




<button onclick="toggleFullScreen()"
  class="btn btn-sm btn-fullscreen-button"
  title="Fullscreen mode"
  data-bs-placement="bottom" data-bs-toggle="tooltip"
>
  

<span class="btn__icon-container">
  <i class="fas fa-expand"></i>
  </span>

</button>


<script>
document.write(`
  <button class="theme-switch-button btn btn-sm btn-outline-primary navbar-btn rounded-circle" title="light/dark" aria-label="light/dark" data-bs-placement="bottom" data-bs-toggle="tooltip">
    <span class="theme-switch" data-mode="light"><i class="fa-solid fa-sun"></i></span>
    <span class="theme-switch" data-mode="dark"><i class="fa-solid fa-moon"></i></span>
    <span class="theme-switch" data-mode="auto"><i class="fa-solid fa-circle-half-stroke"></i></span>
  </button>
`);
</script>

<script>
document.write(`
  <button class="btn btn-sm navbar-btn search-button search-button__button" title="Search" aria-label="Search" data-bs-placement="bottom" data-bs-toggle="tooltip">
    <i class="fa-solid fa-magnifying-glass"></i>
  </button>
`);
</script>
<label class="sidebar-toggle secondary-toggle btn btn-sm" for="__secondary"title="Toggle secondary sidebar" data-bs-placement="bottom" data-bs-toggle="tooltip">
    <span class="fa-solid fa-list"></span>
</label>
</div></div>
      
    </div>
  
</div>
</div>
              
              

<div id="jb-print-docs-body" class="onlyprint">
    <h1>Bar Chart</h1>
    <!-- Table of contents -->
    <div id="print-main-content">
        <div id="jb-print-toc">
            
            <div>
                <h2> Contents </h2>
            </div>
            <nav aria-label="Page">
                <ul class="visible nav section-nav flex-column">
<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#">Bar Chart</a><ul class="visible nav section-nav flex-column">
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#playground-data">Playground Data</a></li>
</ul>
</li>
<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#data-viz-as-exploratory-data-analysis">Data Viz as exploratory data analysis</a><ul class="visible nav section-nav flex-column">
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#preview-the-data">Preview the data</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#base-bar-chart">Base Bar Chart</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#adding-a-tooltip">Adding a Tooltip</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#reorder-y-axis-status-by-x-axis-count">Reorder Y-axis (status) by x-axis (count)</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#add-color-encoding">Add Color encoding</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#remove-unnecesary-titles">Remove Unnecesary Titles</a></li>
</ul>
</li>
</ul>

            </nav>
        </div>
    </div>
</div>

              
                
<div id="searchbox"></div>
                <article class="bd-article" role="main">
                  
  <section class="tex2jax_ignore mathjax_ignore" id="bar-chart">
<h1>Bar Chart<a class="headerlink" href="#bar-chart" title="Permalink to this heading">#</a></h1>
<p>Bar chart is the bread and butter of data visualization. You can basically meet 90% of data analytics needs with bar chart.</p>
<div class="sd-container-fluid sd-sphinx-override sd-mb-4 docutils">
<div class="sd-row sd-g-3 sd-g-xs-3 sd-g-sm-3 sd-g-md-3 sd-g-lg-3 docutils">
<div class="sd-col sd-d-flex-row docutils">
<div class="sd-card sd-sphinx-override sd-w-100 sd-shadow-sm docutils">
<div class="sd-card-body docutils">
<div class="sd-card-title sd-font-weight-bold docutils">
Motivation</div>
<p class="sd-card-text">Often, online examples have 1 final example with 50-line chart-generating code, which can be daunting for begginers. I aim to to display, incremental, line-by-line additions with the corresponding outputs, which is best for learning.</p>
</div>
</div>
</div>
<div class="sd-col sd-d-flex-row docutils">
<div class="sd-card sd-sphinx-override sd-w-100 sd-shadow-sm docutils">
<div class="sd-card-body docutils">
<div class="sd-card-title sd-font-weight-bold docutils">
Approach</div>
<p class="sd-card-text">Typically, most data visualization experts usually do it for creating “dashboard” output, but for me, data visualization is a mechanism to understand data, and often few of the output ends up becoming useful by chance.</p>
</div>
</div>
</div>
</div>
</div>
<p>The “iterative” development is often unintentionally discouraged given today’s “Scrum” culture - you need to definite your X and Y before you even get to the data. Data analysis, especially on new data, requires a lot of exploration.</p>
<section id="playground-data">
<h2>Playground Data<a class="headerlink" href="#playground-data" title="Permalink to this heading">#</a></h2>
<p>Polars is my favorite dataframe library. There is an interesting open-source effort in biomedical space called OpenTargets.</p>
<p>Downloaded the (tab-separated value) from OpenTargets:</p>
<p><img alt="Alt text" src="../_images/iga_neph.png" /></p>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">polars</span> <span class="k">as</span> <span class="nn">pl</span>

<span class="n">df</span> <span class="o">=</span> <span class="n">pl</span><span class="o">.</span><span class="n">read_csv</span><span class="p">(</span><span class="s2">&quot;data/EFO_0004194-known-drugs.tsv&quot;</span><span class="p">,</span> <span class="n">separator</span><span class="o">=</span><span class="s2">&quot;</span><span class="se">\t</span><span class="s2">&quot;</span><span class="p">)</span>
<span class="n">df</span><span class="o">.</span><span class="n">head</span><span class="p">(</span><span class="mi">5</span><span class="p">)</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html"><div><style>
.dataframe > thead > tr > th,
.dataframe > tbody > tr > td {
  text-align: right;
}
</style>
<small>shape: (5, 12)</small><table border="1" class="dataframe"><thead><tr><th>diseaseId</th><th>diseaseName</th><th>drugId</th><th>drugName</th><th>type</th><th>mechanismOfAction</th><th>actionType</th><th>symbol</th><th>name</th><th>phase</th><th>status</th><th>source</th></tr><tr><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>i64</td><td>str</td><td>str</td></tr></thead><tbody><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL429910&quot;</td><td>&quot;DAPAGLIFLOZIN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Sodium/glucose…</td><td>&quot;Inhibitor&quot;</td><td>&quot;SLC5A2&quot;</td><td>&quot;solute carrier…</td><td>4</td><td>&quot;Not yet recrui…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1168&quot;</td><td>&quot;RAMIPRIL&quot;</td><td>&quot;Small molecule…</td><td>&quot;Angiotensin-co…</td><td>&quot;Inhibitor&quot;</td><td>&quot;ACE&quot;</td><td>&quot;angiotensin I …</td><td>4</td><td>&quot;Not yet recrui…</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1535&quot;</td><td>&quot;HYDROXYCHLOROQ…</td><td>&quot;Small molecule…</td><td>&quot;Toll-like rece…</td><td>&quot;Antagonist&quot;</td><td>&quot;TLR7&quot;</td><td>&quot;toll like rece…</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL1639&quot;</td><td>&quot;ALISKIREN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Renin inhibito…</td><td>&quot;Inhibitor&quot;</td><td>&quot;REN&quot;</td><td>&quot;renin&quot;</td><td>4</td><td>&quot;Completed&quot;</td><td>&quot;https://clinic…</td></tr><tr><td>&quot;EFO_0004194&quot;</td><td>&quot;IGA glomerulon…</td><td>&quot;CHEMBL4594217&quot;</td><td>&quot;CANAGLIFLOZIN&quot;</td><td>&quot;Small molecule…</td><td>&quot;Sodium/glucose…</td><td>&quot;Inhibitor&quot;</td><td>&quot;SLC5A2&quot;</td><td>&quot;solute carrier…</td><td>4</td><td>&quot;Not yet recrui…</td><td>&quot;https://clinic…</td></tr></tbody></table></div></div></div>
</div>
</section>
</section>
<section class="tex2jax_ignore mathjax_ignore" id="data-viz-as-exploratory-data-analysis">
<h1>Data Viz as exploratory data analysis<a class="headerlink" href="#data-viz-as-exploratory-data-analysis" title="Permalink to this heading">#</a></h1>
<section id="preview-the-data">
<h2>Preview the data<a class="headerlink" href="#preview-the-data" title="Permalink to this heading">#</a></h2>
<p>For starters, an easy way to explore complex datasets like this is to explore seemingly obvious ones.</p>
<p>The data contains:</p>
<ul class="simple">
<li><p>row-by-row information for disease IgA glomerulonephritis (IgA nephropathy)</p></li>
</ul>
</section>
<section id="base-bar-chart">
<h2>Base Bar Chart<a class="headerlink" href="#base-bar-chart" title="Permalink to this heading">#</a></h2>
<p><code class="docutils literal notranslate"><span class="pre">status</span></code> column is relatively understandable, even if you don’t come from biomedical background.</p>
<p>Let’s start with plotting a count of different <code class="docutils literal notranslate"><span class="pre">status</span></code> counts.</p>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">altair</span> <span class="k">as</span> <span class="nn">alt</span>

<span class="n">fig</span> <span class="o">=</span> <span class="p">(</span>
    <span class="n">alt</span><span class="o">.</span><span class="n">Chart</span><span class="p">(</span><span class="n">df</span><span class="p">)</span><span class="o">.</span><span class="n">mark_bar</span><span class="p">()</span><span class="o">.</span><span class="n">encode</span><span class="p">(</span>
        <span class="n">x</span><span class="o">=</span><span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span>
        <span class="n">y</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">X</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span>
    <span class="p">)</span>
<span class="p">)</span>

<span class="n">fig</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html">
<style>
  #altair-viz-b1ffd47661c74654a79874b7a6dfc0c5.vega-embed {
    width: 100%;
    display: flex;
  }

  #altair-viz-b1ffd47661c74654a79874b7a6dfc0c5.vega-embed details,
  #altair-viz-b1ffd47661c74654a79874b7a6dfc0c5.vega-embed details summary {
    position: relative;
  }
</style>
<div id="altair-viz-b1ffd47661c74654a79874b7a6dfc0c5"></div>
<script type="text/javascript">
  var VEGA_DEBUG = (typeof VEGA_DEBUG == "undefined") ? {} : VEGA_DEBUG;
  (function(spec, embedOpt){
    let outputDiv = document.currentScript.previousElementSibling;
    if (outputDiv.id !== "altair-viz-b1ffd47661c74654a79874b7a6dfc0c5") {
      outputDiv = document.getElementById("altair-viz-b1ffd47661c74654a79874b7a6dfc0c5");
    }
    const paths = {
      "vega": "https://cdn.jsdelivr.net/npm/vega@5?noext",
      "vega-lib": "https://cdn.jsdelivr.net/npm/vega-lib?noext",
      "vega-lite": "https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext",
      "vega-embed": "https://cdn.jsdelivr.net/npm/vega-embed@6?noext",
    };

    function maybeLoadScript(lib, version) {
      var key = `${lib.replace("-", "")}_version`;
      return (VEGA_DEBUG[key] == version) ?
        Promise.resolve(paths[lib]) :
        new Promise(function(resolve, reject) {
          var s = document.createElement('script');
          document.getElementsByTagName("head")[0].appendChild(s);
          s.async = true;
          s.onload = () => {
            VEGA_DEBUG[key] = version;
            return resolve(paths[lib]);
          };
          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);
          s.src = paths[lib];
        });
    }

    function showError(err) {
      outputDiv.innerHTML = `<div class="error" style="color:red;">${err}</div>`;
      throw err;
    }

    function displayChart(vegaEmbed) {
      vegaEmbed(outputDiv, spec, embedOpt)
        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));
    }

    if(typeof define === "function" && define.amd) {
      requirejs.config({paths});
      require(["vega-embed"], displayChart, err => showError(`Error loading script: ${err.message}`));
    } else {
      maybeLoadScript("vega", "5")
        .then(() => maybeLoadScript("vega-lite", "5.8.0"))
        .then(() => maybeLoadScript("vega-embed", "6"))
        .catch(showError)
        .then(() => displayChart(vegaEmbed));
    }
  })({"config": {"view": {"continuousWidth": 300, "continuousHeight": 300}}, "data": {"name": "data-d8b010d8a623bfd2a3ba7a368b00fc84"}, "mark": {"type": "bar"}, "encoding": {"x": {"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, "y": {"field": "status", "type": "nominal"}}, "$schema": "https://vega.github.io/schema/vega-lite/v5.8.0.json", "datasets": {"data-d8b010d8a623bfd2a3ba7a368b00fc84": [{"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL429910", "drugName": "DAPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00922311"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594217", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL608", "drugName": "PROBUCOL", "type": "Small molecule", "mechanismOfAction": "ATP-binding cassette sub-family A member 1 inhibitor", "actionType": "Inhibitor", "symbol": "ABCA1", "name": "ATP binding cassette subfamily A member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02231125"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT01758120"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04525729"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03218852"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02571842"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1237", "drugName": "LISINOPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00498368"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2048484", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107830", "drugName": "EMPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL846", "drugName": "CALCITRIOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00319761"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00870493"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03357653"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL9194", "drugName": "ATRASENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04573478"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4298195", "drugName": "NARSOPLIMAB", "type": "Antibody", "mechanismOfAction": "Mannan-binding lectin serine protease 2 inhibitor", "actionType": "Inhibitor", "symbol": "MASP2", "name": "MBL associated serine protease 2", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03608033"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05510323"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02052219"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02232776"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1200622", "drugName": "PARICALCITOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT00599963"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04833374"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02062684"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03373461"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00004448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL393220", "drugName": "ATORVASTATIN CALCIUM", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02662283"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594462", "drugName": "BATIRAXCEPT", "type": "Protein", "mechanismOfAction": "Growth arrest-specific protein 6 inhibitor", "actionType": "Inhibitor", "symbol": "GAS6", "name": "growth arrest specific 6", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT04042623"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL413", "drugName": "SIROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL269732", "drugName": "TACROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01224028"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594460", "drugName": "AT-1501", "type": "Unknown", "mechanismOfAction": "CD40 ligand inhibitor", "actionType": "Inhibitor", "symbol": "CD40LG", "name": "CD40 ligand", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05125068"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04287985"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594579", "drugName": "FELZARTAMAB", "type": "Antibody", "mechanismOfAction": "Lymphocyte differentiation antigen CD38 inhibitor", "actionType": "Inhibitor", "symbol": "CD38", "name": "CD38 molecule", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05065970"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1487", "drugName": "ATORVASTATIN", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989871", "drugName": "AVACOPAN", "type": "Small molecule", "mechanismOfAction": "C5a anaphylatoxin chemotactic receptor antagonist", "actionType": "Antagonist", "symbol": "C5AR1", "name": "complement C5a receptor 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02384317"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1370", "drugName": "BUDESONIDE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00767221"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02112838"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989516", "drugName": "FOSTAMATINIB DISODIUM", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4297722", "drugName": "CEMDISIRAN", "type": "Oligonucleotide", "mechanismOfAction": "Complement C5 mRNA RNAi inhibitor", "actionType": "Rnai inhibitor", "symbol": "C5", "name": "complement C5", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03841448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 1, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03719443"}]}}, {"mode": "vega-lite"});
</script></div></div>
</div>
</section>
<section id="adding-a-tooltip">
<h2>Adding a Tooltip<a class="headerlink" href="#adding-a-tooltip" title="Permalink to this heading">#</a></h2>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">altair</span> <span class="k">as</span> <span class="nn">alt</span>

<span class="n">fig</span> <span class="o">=</span> <span class="p">(</span>
    <span class="n">alt</span><span class="o">.</span><span class="n">Chart</span><span class="p">(</span><span class="n">df</span><span class="p">)</span><span class="o">.</span><span class="n">mark_bar</span><span class="p">()</span><span class="o">.</span><span class="n">encode</span><span class="p">(</span>
        <span class="n">x</span><span class="o">=</span><span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span>
        <span class="n">y</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Y</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">),</span>
        <span class="n">tooltip</span><span class="o">=</span><span class="p">[</span>
            <span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span> 
            <span class="s2">&quot;status:N&quot;</span>
        <span class="p">]</span>
    <span class="p">)</span>
<span class="p">)</span>

<span class="n">fig</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html">
<style>
  #altair-viz-5f1073f0643e4ffd9baa69be27b35571.vega-embed {
    width: 100%;
    display: flex;
  }

  #altair-viz-5f1073f0643e4ffd9baa69be27b35571.vega-embed details,
  #altair-viz-5f1073f0643e4ffd9baa69be27b35571.vega-embed details summary {
    position: relative;
  }
</style>
<div id="altair-viz-5f1073f0643e4ffd9baa69be27b35571"></div>
<script type="text/javascript">
  var VEGA_DEBUG = (typeof VEGA_DEBUG == "undefined") ? {} : VEGA_DEBUG;
  (function(spec, embedOpt){
    let outputDiv = document.currentScript.previousElementSibling;
    if (outputDiv.id !== "altair-viz-5f1073f0643e4ffd9baa69be27b35571") {
      outputDiv = document.getElementById("altair-viz-5f1073f0643e4ffd9baa69be27b35571");
    }
    const paths = {
      "vega": "https://cdn.jsdelivr.net/npm/vega@5?noext",
      "vega-lib": "https://cdn.jsdelivr.net/npm/vega-lib?noext",
      "vega-lite": "https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext",
      "vega-embed": "https://cdn.jsdelivr.net/npm/vega-embed@6?noext",
    };

    function maybeLoadScript(lib, version) {
      var key = `${lib.replace("-", "")}_version`;
      return (VEGA_DEBUG[key] == version) ?
        Promise.resolve(paths[lib]) :
        new Promise(function(resolve, reject) {
          var s = document.createElement('script');
          document.getElementsByTagName("head")[0].appendChild(s);
          s.async = true;
          s.onload = () => {
            VEGA_DEBUG[key] = version;
            return resolve(paths[lib]);
          };
          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);
          s.src = paths[lib];
        });
    }

    function showError(err) {
      outputDiv.innerHTML = `<div class="error" style="color:red;">${err}</div>`;
      throw err;
    }

    function displayChart(vegaEmbed) {
      vegaEmbed(outputDiv, spec, embedOpt)
        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));
    }

    if(typeof define === "function" && define.amd) {
      requirejs.config({paths});
      require(["vega-embed"], displayChart, err => showError(`Error loading script: ${err.message}`));
    } else {
      maybeLoadScript("vega", "5")
        .then(() => maybeLoadScript("vega-lite", "5.8.0"))
        .then(() => maybeLoadScript("vega-embed", "6"))
        .catch(showError)
        .then(() => displayChart(vegaEmbed));
    }
  })({"config": {"view": {"continuousWidth": 300, "continuousHeight": 300}}, "data": {"name": "data-d8b010d8a623bfd2a3ba7a368b00fc84"}, "mark": {"type": "bar"}, "encoding": {"tooltip": [{"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, {"field": "status", "type": "nominal"}], "x": {"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, "y": {"field": "status", "type": "nominal"}}, "$schema": "https://vega.github.io/schema/vega-lite/v5.8.0.json", "datasets": {"data-d8b010d8a623bfd2a3ba7a368b00fc84": [{"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL429910", "drugName": "DAPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00922311"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594217", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL608", "drugName": "PROBUCOL", "type": "Small molecule", "mechanismOfAction": "ATP-binding cassette sub-family A member 1 inhibitor", "actionType": "Inhibitor", "symbol": "ABCA1", "name": "ATP binding cassette subfamily A member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02231125"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT01758120"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04525729"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03218852"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02571842"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1237", "drugName": "LISINOPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00498368"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2048484", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107830", "drugName": "EMPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL846", "drugName": "CALCITRIOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00319761"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00870493"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03357653"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL9194", "drugName": "ATRASENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04573478"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4298195", "drugName": "NARSOPLIMAB", "type": "Antibody", "mechanismOfAction": "Mannan-binding lectin serine protease 2 inhibitor", "actionType": "Inhibitor", "symbol": "MASP2", "name": "MBL associated serine protease 2", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03608033"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05510323"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02052219"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02232776"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1200622", "drugName": "PARICALCITOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT00599963"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04833374"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02062684"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03373461"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00004448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL393220", "drugName": "ATORVASTATIN CALCIUM", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02662283"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594462", "drugName": "BATIRAXCEPT", "type": "Protein", "mechanismOfAction": "Growth arrest-specific protein 6 inhibitor", "actionType": "Inhibitor", "symbol": "GAS6", "name": "growth arrest specific 6", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT04042623"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL413", "drugName": "SIROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL269732", "drugName": "TACROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01224028"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594460", "drugName": "AT-1501", "type": "Unknown", "mechanismOfAction": "CD40 ligand inhibitor", "actionType": "Inhibitor", "symbol": "CD40LG", "name": "CD40 ligand", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05125068"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04287985"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594579", "drugName": "FELZARTAMAB", "type": "Antibody", "mechanismOfAction": "Lymphocyte differentiation antigen CD38 inhibitor", "actionType": "Inhibitor", "symbol": "CD38", "name": "CD38 molecule", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05065970"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1487", "drugName": "ATORVASTATIN", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989871", "drugName": "AVACOPAN", "type": "Small molecule", "mechanismOfAction": "C5a anaphylatoxin chemotactic receptor antagonist", "actionType": "Antagonist", "symbol": "C5AR1", "name": "complement C5a receptor 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02384317"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1370", "drugName": "BUDESONIDE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00767221"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02112838"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989516", "drugName": "FOSTAMATINIB DISODIUM", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4297722", "drugName": "CEMDISIRAN", "type": "Oligonucleotide", "mechanismOfAction": "Complement C5 mRNA RNAi inhibitor", "actionType": "Rnai inhibitor", "symbol": "C5", "name": "complement C5", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03841448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 1, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03719443"}]}}, {"mode": "vega-lite"});
</script></div></div>
</div>
</section>
<section id="reorder-y-axis-status-by-x-axis-count">
<h2>Reorder Y-axis (status) by x-axis (count)<a class="headerlink" href="#reorder-y-axis-status-by-x-axis-count" title="Permalink to this heading">#</a></h2>
<p>Altair syntax allows you to sort by another field. In our case, we want to sort by the data result mapped to “x” (which is <code class="docutils literal notranslate"><span class="pre">distinct(drugId)</span></code>) but in descending order.</p>
<p>When you start to add in more complex encodings and parameters, you have to start using Altair’s object representations such as <code class="docutils literal notranslate"><span class="pre">alt.X()</span></code> or <code class="docutils literal notranslate"><span class="pre">alt.Color()</span></code> rather than the column names themselves (this is a shortcut to an extent)</p>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">altair</span> <span class="k">as</span> <span class="nn">alt</span>

<span class="n">fig</span> <span class="o">=</span> <span class="p">(</span>
    <span class="n">alt</span><span class="o">.</span><span class="n">Chart</span><span class="p">(</span><span class="n">df</span><span class="p">)</span><span class="o">.</span><span class="n">mark_bar</span><span class="p">()</span><span class="o">.</span><span class="n">encode</span><span class="p">(</span>
        <span class="n">x</span><span class="o">=</span><span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span>
        <span class="n">y</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Y</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">sort</span><span class="p">(</span><span class="s2">&quot;-x&quot;</span><span class="p">),</span>
        <span class="n">tooltip</span><span class="o">=</span><span class="p">[</span>
            <span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span> 
            <span class="s2">&quot;status:N&quot;</span>
        <span class="p">]</span>
    <span class="p">)</span>
<span class="p">)</span>

<span class="n">fig</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html">
<style>
  #altair-viz-3fa8d179dedf4bdb86f2847ac9254779.vega-embed {
    width: 100%;
    display: flex;
  }

  #altair-viz-3fa8d179dedf4bdb86f2847ac9254779.vega-embed details,
  #altair-viz-3fa8d179dedf4bdb86f2847ac9254779.vega-embed details summary {
    position: relative;
  }
</style>
<div id="altair-viz-3fa8d179dedf4bdb86f2847ac9254779"></div>
<script type="text/javascript">
  var VEGA_DEBUG = (typeof VEGA_DEBUG == "undefined") ? {} : VEGA_DEBUG;
  (function(spec, embedOpt){
    let outputDiv = document.currentScript.previousElementSibling;
    if (outputDiv.id !== "altair-viz-3fa8d179dedf4bdb86f2847ac9254779") {
      outputDiv = document.getElementById("altair-viz-3fa8d179dedf4bdb86f2847ac9254779");
    }
    const paths = {
      "vega": "https://cdn.jsdelivr.net/npm/vega@5?noext",
      "vega-lib": "https://cdn.jsdelivr.net/npm/vega-lib?noext",
      "vega-lite": "https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext",
      "vega-embed": "https://cdn.jsdelivr.net/npm/vega-embed@6?noext",
    };

    function maybeLoadScript(lib, version) {
      var key = `${lib.replace("-", "")}_version`;
      return (VEGA_DEBUG[key] == version) ?
        Promise.resolve(paths[lib]) :
        new Promise(function(resolve, reject) {
          var s = document.createElement('script');
          document.getElementsByTagName("head")[0].appendChild(s);
          s.async = true;
          s.onload = () => {
            VEGA_DEBUG[key] = version;
            return resolve(paths[lib]);
          };
          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);
          s.src = paths[lib];
        });
    }

    function showError(err) {
      outputDiv.innerHTML = `<div class="error" style="color:red;">${err}</div>`;
      throw err;
    }

    function displayChart(vegaEmbed) {
      vegaEmbed(outputDiv, spec, embedOpt)
        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));
    }

    if(typeof define === "function" && define.amd) {
      requirejs.config({paths});
      require(["vega-embed"], displayChart, err => showError(`Error loading script: ${err.message}`));
    } else {
      maybeLoadScript("vega", "5")
        .then(() => maybeLoadScript("vega-lite", "5.8.0"))
        .then(() => maybeLoadScript("vega-embed", "6"))
        .catch(showError)
        .then(() => displayChart(vegaEmbed));
    }
  })({"config": {"view": {"continuousWidth": 300, "continuousHeight": 300}}, "data": {"name": "data-d8b010d8a623bfd2a3ba7a368b00fc84"}, "mark": {"type": "bar"}, "encoding": {"tooltip": [{"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, {"field": "status", "type": "nominal"}], "x": {"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, "y": {"field": "status", "sort": "-x", "type": "nominal"}}, "$schema": "https://vega.github.io/schema/vega-lite/v5.8.0.json", "datasets": {"data-d8b010d8a623bfd2a3ba7a368b00fc84": [{"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL429910", "drugName": "DAPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00922311"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594217", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL608", "drugName": "PROBUCOL", "type": "Small molecule", "mechanismOfAction": "ATP-binding cassette sub-family A member 1 inhibitor", "actionType": "Inhibitor", "symbol": "ABCA1", "name": "ATP binding cassette subfamily A member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02231125"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT01758120"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04525729"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03218852"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02571842"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1237", "drugName": "LISINOPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00498368"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2048484", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107830", "drugName": "EMPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL846", "drugName": "CALCITRIOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00319761"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00870493"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03357653"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL9194", "drugName": "ATRASENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04573478"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4298195", "drugName": "NARSOPLIMAB", "type": "Antibody", "mechanismOfAction": "Mannan-binding lectin serine protease 2 inhibitor", "actionType": "Inhibitor", "symbol": "MASP2", "name": "MBL associated serine protease 2", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03608033"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05510323"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02052219"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02232776"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1200622", "drugName": "PARICALCITOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT00599963"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04833374"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02062684"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03373461"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00004448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL393220", "drugName": "ATORVASTATIN CALCIUM", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02662283"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594462", "drugName": "BATIRAXCEPT", "type": "Protein", "mechanismOfAction": "Growth arrest-specific protein 6 inhibitor", "actionType": "Inhibitor", "symbol": "GAS6", "name": "growth arrest specific 6", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT04042623"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL413", "drugName": "SIROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL269732", "drugName": "TACROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01224028"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594460", "drugName": "AT-1501", "type": "Unknown", "mechanismOfAction": "CD40 ligand inhibitor", "actionType": "Inhibitor", "symbol": "CD40LG", "name": "CD40 ligand", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05125068"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04287985"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594579", "drugName": "FELZARTAMAB", "type": "Antibody", "mechanismOfAction": "Lymphocyte differentiation antigen CD38 inhibitor", "actionType": "Inhibitor", "symbol": "CD38", "name": "CD38 molecule", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05065970"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1487", "drugName": "ATORVASTATIN", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989871", "drugName": "AVACOPAN", "type": "Small molecule", "mechanismOfAction": "C5a anaphylatoxin chemotactic receptor antagonist", "actionType": "Antagonist", "symbol": "C5AR1", "name": "complement C5a receptor 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02384317"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1370", "drugName": "BUDESONIDE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00767221"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02112838"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989516", "drugName": "FOSTAMATINIB DISODIUM", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4297722", "drugName": "CEMDISIRAN", "type": "Oligonucleotide", "mechanismOfAction": "Complement C5 mRNA RNAi inhibitor", "actionType": "Rnai inhibitor", "symbol": "C5", "name": "complement C5", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03841448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 1, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03719443"}]}}, {"mode": "vega-lite"});
</script></div></div>
</div>
</section>
<section id="add-color-encoding">
<h2>Add Color encoding<a class="headerlink" href="#add-color-encoding" title="Permalink to this heading">#</a></h2>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">altair</span> <span class="k">as</span> <span class="nn">alt</span>

<span class="n">fig</span> <span class="o">=</span> <span class="p">(</span>
    <span class="n">alt</span><span class="o">.</span><span class="n">Chart</span><span class="p">(</span><span class="n">df</span><span class="p">)</span><span class="o">.</span><span class="n">mark_bar</span><span class="p">()</span><span class="o">.</span><span class="n">encode</span><span class="p">(</span>
        <span class="n">x</span><span class="o">=</span><span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span>
        <span class="n">y</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Y</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">sort</span><span class="p">(</span><span class="s2">&quot;-x&quot;</span><span class="p">),</span>
        <span class="n">color</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Color</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">),</span>
        <span class="n">tooltip</span><span class="o">=</span><span class="p">[</span>
            <span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span> 
            <span class="s2">&quot;status:N&quot;</span>
        <span class="p">]</span>
    <span class="p">)</span>
<span class="p">)</span>

<span class="n">fig</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html">
<style>
  #altair-viz-5771db89da6c496d9823baad277d5a68.vega-embed {
    width: 100%;
    display: flex;
  }

  #altair-viz-5771db89da6c496d9823baad277d5a68.vega-embed details,
  #altair-viz-5771db89da6c496d9823baad277d5a68.vega-embed details summary {
    position: relative;
  }
</style>
<div id="altair-viz-5771db89da6c496d9823baad277d5a68"></div>
<script type="text/javascript">
  var VEGA_DEBUG = (typeof VEGA_DEBUG == "undefined") ? {} : VEGA_DEBUG;
  (function(spec, embedOpt){
    let outputDiv = document.currentScript.previousElementSibling;
    if (outputDiv.id !== "altair-viz-5771db89da6c496d9823baad277d5a68") {
      outputDiv = document.getElementById("altair-viz-5771db89da6c496d9823baad277d5a68");
    }
    const paths = {
      "vega": "https://cdn.jsdelivr.net/npm/vega@5?noext",
      "vega-lib": "https://cdn.jsdelivr.net/npm/vega-lib?noext",
      "vega-lite": "https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext",
      "vega-embed": "https://cdn.jsdelivr.net/npm/vega-embed@6?noext",
    };

    function maybeLoadScript(lib, version) {
      var key = `${lib.replace("-", "")}_version`;
      return (VEGA_DEBUG[key] == version) ?
        Promise.resolve(paths[lib]) :
        new Promise(function(resolve, reject) {
          var s = document.createElement('script');
          document.getElementsByTagName("head")[0].appendChild(s);
          s.async = true;
          s.onload = () => {
            VEGA_DEBUG[key] = version;
            return resolve(paths[lib]);
          };
          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);
          s.src = paths[lib];
        });
    }

    function showError(err) {
      outputDiv.innerHTML = `<div class="error" style="color:red;">${err}</div>`;
      throw err;
    }

    function displayChart(vegaEmbed) {
      vegaEmbed(outputDiv, spec, embedOpt)
        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));
    }

    if(typeof define === "function" && define.amd) {
      requirejs.config({paths});
      require(["vega-embed"], displayChart, err => showError(`Error loading script: ${err.message}`));
    } else {
      maybeLoadScript("vega", "5")
        .then(() => maybeLoadScript("vega-lite", "5.8.0"))
        .then(() => maybeLoadScript("vega-embed", "6"))
        .catch(showError)
        .then(() => displayChart(vegaEmbed));
    }
  })({"config": {"view": {"continuousWidth": 300, "continuousHeight": 300}}, "data": {"name": "data-d8b010d8a623bfd2a3ba7a368b00fc84"}, "mark": {"type": "bar"}, "encoding": {"color": {"field": "status", "type": "nominal"}, "tooltip": [{"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, {"field": "status", "type": "nominal"}], "x": {"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, "y": {"field": "status", "sort": "-x", "type": "nominal"}}, "$schema": "https://vega.github.io/schema/vega-lite/v5.8.0.json", "datasets": {"data-d8b010d8a623bfd2a3ba7a368b00fc84": [{"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL429910", "drugName": "DAPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00922311"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594217", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL608", "drugName": "PROBUCOL", "type": "Small molecule", "mechanismOfAction": "ATP-binding cassette sub-family A member 1 inhibitor", "actionType": "Inhibitor", "symbol": "ABCA1", "name": "ATP binding cassette subfamily A member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02231125"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT01758120"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04525729"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03218852"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02571842"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1237", "drugName": "LISINOPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00498368"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2048484", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107830", "drugName": "EMPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL846", "drugName": "CALCITRIOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00319761"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00870493"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03357653"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL9194", "drugName": "ATRASENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04573478"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4298195", "drugName": "NARSOPLIMAB", "type": "Antibody", "mechanismOfAction": "Mannan-binding lectin serine protease 2 inhibitor", "actionType": "Inhibitor", "symbol": "MASP2", "name": "MBL associated serine protease 2", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03608033"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05510323"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02052219"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02232776"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1200622", "drugName": "PARICALCITOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT00599963"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04833374"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02062684"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03373461"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00004448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL393220", "drugName": "ATORVASTATIN CALCIUM", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02662283"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594462", "drugName": "BATIRAXCEPT", "type": "Protein", "mechanismOfAction": "Growth arrest-specific protein 6 inhibitor", "actionType": "Inhibitor", "symbol": "GAS6", "name": "growth arrest specific 6", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT04042623"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL413", "drugName": "SIROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL269732", "drugName": "TACROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01224028"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594460", "drugName": "AT-1501", "type": "Unknown", "mechanismOfAction": "CD40 ligand inhibitor", "actionType": "Inhibitor", "symbol": "CD40LG", "name": "CD40 ligand", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05125068"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04287985"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594579", "drugName": "FELZARTAMAB", "type": "Antibody", "mechanismOfAction": "Lymphocyte differentiation antigen CD38 inhibitor", "actionType": "Inhibitor", "symbol": "CD38", "name": "CD38 molecule", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05065970"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1487", "drugName": "ATORVASTATIN", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989871", "drugName": "AVACOPAN", "type": "Small molecule", "mechanismOfAction": "C5a anaphylatoxin chemotactic receptor antagonist", "actionType": "Antagonist", "symbol": "C5AR1", "name": "complement C5a receptor 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02384317"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1370", "drugName": "BUDESONIDE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00767221"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02112838"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989516", "drugName": "FOSTAMATINIB DISODIUM", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4297722", "drugName": "CEMDISIRAN", "type": "Oligonucleotide", "mechanismOfAction": "Complement C5 mRNA RNAi inhibitor", "actionType": "Rnai inhibitor", "symbol": "C5", "name": "complement C5", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03841448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 1, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03719443"}]}}, {"mode": "vega-lite"});
</script></div></div>
</div>
</section>
<section id="remove-unnecesary-titles">
<h2>Remove Unnecesary Titles<a class="headerlink" href="#remove-unnecesary-titles" title="Permalink to this heading">#</a></h2>
<p>Many times, I find titles unnecessary or not-presentation ready.</p>
<p>For such cases, it’s very easy to modify encoding channel titles (e.g. axis titles, legend titles) in Altair.</p>
<p>Use <code class="docutils literal notranslate"><span class="pre">.title()</span></code> after each encoding definition.</p>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">altair</span> <span class="k">as</span> <span class="nn">alt</span>

<span class="n">fig</span> <span class="o">=</span> <span class="p">(</span>
    <span class="n">alt</span><span class="o">.</span><span class="n">Chart</span><span class="p">(</span><span class="n">df</span><span class="p">)</span><span class="o">.</span><span class="n">mark_bar</span><span class="p">()</span><span class="o">.</span><span class="n">encode</span><span class="p">(</span>
        <span class="n">x</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">X</span><span class="p">(</span><span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">title</span><span class="p">(</span><span class="s2">&quot;Unique Drugs&quot;</span><span class="p">),</span>
        <span class="n">y</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Y</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">sort</span><span class="p">(</span><span class="s2">&quot;-x&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">title</span><span class="p">(</span><span class="s2">&quot;Status&quot;</span><span class="p">),</span>
        <span class="n">color</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Color</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">title</span><span class="p">(</span><span class="kc">None</span><span class="p">),</span>
        <span class="n">tooltip</span><span class="o">=</span><span class="p">[</span>
            <span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span> 
            <span class="s2">&quot;status:N&quot;</span>
        <span class="p">]</span>
    <span class="p">)</span>
<span class="p">)</span>

<span class="n">fig</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html">
<style>
  #altair-viz-de0682c8551842d3a3218c703c0ba8d3.vega-embed {
    width: 100%;
    display: flex;
  }

  #altair-viz-de0682c8551842d3a3218c703c0ba8d3.vega-embed details,
  #altair-viz-de0682c8551842d3a3218c703c0ba8d3.vega-embed details summary {
    position: relative;
  }
</style>
<div id="altair-viz-de0682c8551842d3a3218c703c0ba8d3"></div>
<script type="text/javascript">
  var VEGA_DEBUG = (typeof VEGA_DEBUG == "undefined") ? {} : VEGA_DEBUG;
  (function(spec, embedOpt){
    let outputDiv = document.currentScript.previousElementSibling;
    if (outputDiv.id !== "altair-viz-de0682c8551842d3a3218c703c0ba8d3") {
      outputDiv = document.getElementById("altair-viz-de0682c8551842d3a3218c703c0ba8d3");
    }
    const paths = {
      "vega": "https://cdn.jsdelivr.net/npm/vega@5?noext",
      "vega-lib": "https://cdn.jsdelivr.net/npm/vega-lib?noext",
      "vega-lite": "https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext",
      "vega-embed": "https://cdn.jsdelivr.net/npm/vega-embed@6?noext",
    };

    function maybeLoadScript(lib, version) {
      var key = `${lib.replace("-", "")}_version`;
      return (VEGA_DEBUG[key] == version) ?
        Promise.resolve(paths[lib]) :
        new Promise(function(resolve, reject) {
          var s = document.createElement('script');
          document.getElementsByTagName("head")[0].appendChild(s);
          s.async = true;
          s.onload = () => {
            VEGA_DEBUG[key] = version;
            return resolve(paths[lib]);
          };
          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);
          s.src = paths[lib];
        });
    }

    function showError(err) {
      outputDiv.innerHTML = `<div class="error" style="color:red;">${err}</div>`;
      throw err;
    }

    function displayChart(vegaEmbed) {
      vegaEmbed(outputDiv, spec, embedOpt)
        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));
    }

    if(typeof define === "function" && define.amd) {
      requirejs.config({paths});
      require(["vega-embed"], displayChart, err => showError(`Error loading script: ${err.message}`));
    } else {
      maybeLoadScript("vega", "5")
        .then(() => maybeLoadScript("vega-lite", "5.8.0"))
        .then(() => maybeLoadScript("vega-embed", "6"))
        .catch(showError)
        .then(() => displayChart(vegaEmbed));
    }
  })({"config": {"view": {"continuousWidth": 300, "continuousHeight": 300}}, "data": {"name": "data-d8b010d8a623bfd2a3ba7a368b00fc84"}, "mark": {"type": "bar"}, "encoding": {"color": {"field": "status", "title": null, "type": "nominal"}, "tooltip": [{"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, {"field": "status", "type": "nominal"}], "x": {"aggregate": "distinct", "field": "drugId", "title": "Unique Drugs", "type": "quantitative"}, "y": {"field": "status", "sort": "-x", "title": "Status", "type": "nominal"}}, "$schema": "https://vega.github.io/schema/vega-lite/v5.8.0.json", "datasets": {"data-d8b010d8a623bfd2a3ba7a368b00fc84": [{"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL429910", "drugName": "DAPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00922311"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594217", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL608", "drugName": "PROBUCOL", "type": "Small molecule", "mechanismOfAction": "ATP-binding cassette sub-family A member 1 inhibitor", "actionType": "Inhibitor", "symbol": "ABCA1", "name": "ATP binding cassette subfamily A member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02231125"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT01758120"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04525729"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03218852"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02571842"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1237", "drugName": "LISINOPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00498368"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2048484", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107830", "drugName": "EMPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL846", "drugName": "CALCITRIOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00319761"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00870493"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03357653"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL9194", "drugName": "ATRASENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04573478"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4298195", "drugName": "NARSOPLIMAB", "type": "Antibody", "mechanismOfAction": "Mannan-binding lectin serine protease 2 inhibitor", "actionType": "Inhibitor", "symbol": "MASP2", "name": "MBL associated serine protease 2", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03608033"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05510323"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02052219"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02232776"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1200622", "drugName": "PARICALCITOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT00599963"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04833374"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02062684"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03373461"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00004448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL393220", "drugName": "ATORVASTATIN CALCIUM", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02662283"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594462", "drugName": "BATIRAXCEPT", "type": "Protein", "mechanismOfAction": "Growth arrest-specific protein 6 inhibitor", "actionType": "Inhibitor", "symbol": "GAS6", "name": "growth arrest specific 6", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT04042623"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL413", "drugName": "SIROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL269732", "drugName": "TACROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01224028"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594460", "drugName": "AT-1501", "type": "Unknown", "mechanismOfAction": "CD40 ligand inhibitor", "actionType": "Inhibitor", "symbol": "CD40LG", "name": "CD40 ligand", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05125068"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04287985"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594579", "drugName": "FELZARTAMAB", "type": "Antibody", "mechanismOfAction": "Lymphocyte differentiation antigen CD38 inhibitor", "actionType": "Inhibitor", "symbol": "CD38", "name": "CD38 molecule", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05065970"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1487", "drugName": "ATORVASTATIN", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989871", "drugName": "AVACOPAN", "type": "Small molecule", "mechanismOfAction": "C5a anaphylatoxin chemotactic receptor antagonist", "actionType": "Antagonist", "symbol": "C5AR1", "name": "complement C5a receptor 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02384317"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1370", "drugName": "BUDESONIDE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00767221"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02112838"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989516", "drugName": "FOSTAMATINIB DISODIUM", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4297722", "drugName": "CEMDISIRAN", "type": "Oligonucleotide", "mechanismOfAction": "Complement C5 mRNA RNAi inhibitor", "actionType": "Rnai inhibitor", "symbol": "C5", "name": "complement C5", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03841448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 1, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03719443"}]}}, {"mode": "vega-lite"});
</script></div></div>
</div>
<div class="cell docutils container">
<div class="cell_input docutils container">
<div class="highlight-ipython3 notranslate"><div class="highlight"><pre><span></span><span class="kn">import</span> <span class="nn">altair</span> <span class="k">as</span> <span class="nn">alt</span>

<span class="n">fig</span> <span class="o">=</span> <span class="p">(</span>
    <span class="n">alt</span><span class="o">.</span><span class="n">Chart</span><span class="p">(</span><span class="n">df</span><span class="p">)</span><span class="o">.</span><span class="n">mark_bar</span><span class="p">()</span><span class="o">.</span><span class="n">encode</span><span class="p">(</span>
        <span class="n">x</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">X</span><span class="p">(</span><span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">title</span><span class="p">(</span><span class="s2">&quot;Unique Drugs&quot;</span><span class="p">),</span>
        <span class="n">y</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Y</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">sort</span><span class="p">(</span><span class="s2">&quot;-x&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">title</span><span class="p">(</span><span class="s2">&quot;Status&quot;</span><span class="p">),</span>
        <span class="n">color</span><span class="o">=</span><span class="n">alt</span><span class="o">.</span><span class="n">Color</span><span class="p">(</span><span class="s2">&quot;status:N&quot;</span><span class="p">)</span><span class="o">.</span><span class="n">title</span><span class="p">(</span><span class="kc">None</span><span class="p">),</span>
        <span class="n">tooltip</span><span class="o">=</span><span class="p">[</span>
            <span class="s2">&quot;distinct(drugId):Q&quot;</span><span class="p">,</span> 
            <span class="s2">&quot;status:N&quot;</span>
        <span class="p">]</span>
    <span class="p">)</span>
<span class="p">)</span>

<span class="n">fig</span><span class="o">.</span><span class="n">properties</span><span class="p">(</span>
    <span class="n">title</span><span class="o">=</span><span class="s2">&quot;Drug Trials for IgA Nephropathy&quot;</span><span class="p">,</span>
<span class="p">)</span>
</pre></div>
</div>
</div>
<div class="cell_output docutils container">
<div class="output text_html">
<style>
  #altair-viz-1287413b7c444230b4adb74de4f277d3.vega-embed {
    width: 100%;
    display: flex;
  }

  #altair-viz-1287413b7c444230b4adb74de4f277d3.vega-embed details,
  #altair-viz-1287413b7c444230b4adb74de4f277d3.vega-embed details summary {
    position: relative;
  }
</style>
<div id="altair-viz-1287413b7c444230b4adb74de4f277d3"></div>
<script type="text/javascript">
  var VEGA_DEBUG = (typeof VEGA_DEBUG == "undefined") ? {} : VEGA_DEBUG;
  (function(spec, embedOpt){
    let outputDiv = document.currentScript.previousElementSibling;
    if (outputDiv.id !== "altair-viz-1287413b7c444230b4adb74de4f277d3") {
      outputDiv = document.getElementById("altair-viz-1287413b7c444230b4adb74de4f277d3");
    }
    const paths = {
      "vega": "https://cdn.jsdelivr.net/npm/vega@5?noext",
      "vega-lib": "https://cdn.jsdelivr.net/npm/vega-lib?noext",
      "vega-lite": "https://cdn.jsdelivr.net/npm/vega-lite@5.8.0?noext",
      "vega-embed": "https://cdn.jsdelivr.net/npm/vega-embed@6?noext",
    };

    function maybeLoadScript(lib, version) {
      var key = `${lib.replace("-", "")}_version`;
      return (VEGA_DEBUG[key] == version) ?
        Promise.resolve(paths[lib]) :
        new Promise(function(resolve, reject) {
          var s = document.createElement('script');
          document.getElementsByTagName("head")[0].appendChild(s);
          s.async = true;
          s.onload = () => {
            VEGA_DEBUG[key] = version;
            return resolve(paths[lib]);
          };
          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);
          s.src = paths[lib];
        });
    }

    function showError(err) {
      outputDiv.innerHTML = `<div class="error" style="color:red;">${err}</div>`;
      throw err;
    }

    function displayChart(vegaEmbed) {
      vegaEmbed(outputDiv, spec, embedOpt)
        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));
    }

    if(typeof define === "function" && define.amd) {
      requirejs.config({paths});
      require(["vega-embed"], displayChart, err => showError(`Error loading script: ${err.message}`));
    } else {
      maybeLoadScript("vega", "5")
        .then(() => maybeLoadScript("vega-lite", "5.8.0"))
        .then(() => maybeLoadScript("vega-embed", "6"))
        .catch(showError)
        .then(() => displayChart(vegaEmbed));
    }
  })({"config": {"view": {"continuousWidth": 300, "continuousHeight": 300}}, "data": {"name": "data-d8b010d8a623bfd2a3ba7a368b00fc84"}, "mark": {"type": "bar"}, "encoding": {"color": {"field": "status", "title": null, "type": "nominal"}, "tooltip": [{"aggregate": "distinct", "field": "drugId", "type": "quantitative"}, {"field": "status", "type": "nominal"}], "x": {"aggregate": "distinct", "field": "drugId", "title": "Unique Drugs", "type": "quantitative"}, "y": {"field": "status", "sort": "-x", "title": "Status", "type": "nominal"}}, "title": "Drug Trials for IgA Nephropathy", "$schema": "https://vega.github.io/schema/vega-lite/v5.8.0.json", "datasets": {"data-d8b010d8a623bfd2a3ba7a368b00fc84": [{"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL429910", "drugName": "DAPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00922311"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594217", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL608", "drugName": "PROBUCOL", "type": "Small molecule", "mechanismOfAction": "ATP-binding cassette sub-family A member 1 inhibitor", "actionType": "Inhibitor", "symbol": "ABCA1", "name": "ATP binding cassette subfamily A member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02231125"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT01758120"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 9 antagonist", "actionType": "Antagonist", "symbol": "TLR9", "name": "toll like receptor 9", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02351752"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04525729"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1069", "drugName": "VALSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00367562,https://clinicaltrials.gov/ct2/show/NCT00426348"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03218852"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02981212"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02571842"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1690", "drugName": "HYDROXYCHLOROQUINE SULFATE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1237", "drugName": "LISINOPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1535", "drugName": "HYDROXYCHLOROQUINE", "type": "Small molecule", "mechanismOfAction": "Toll-like receptor 7 antagonist", "actionType": "Antagonist", "symbol": "TLR7", "name": "toll like receptor 7", "phase": 4, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02765594"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201576", "drugName": "RITUXIMAB", "type": "Antibody", "mechanismOfAction": "B-lymphocyte antigen CD20 binding agent", "actionType": "Binding agent", "symbol": "MS4A1", "name": "membrane spanning 4-domains A1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00498368"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00863252"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2048484", "drugName": "CANAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107830", "drugName": "EMPAGLIFLOZIN", "type": "Small molecule", "mechanismOfAction": "Sodium/glucose cotransporter 2 inhibitor", "actionType": "Inhibitor", "symbol": "SLC5A2", "name": "solute carrier family 5 member 2", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 4, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04662723"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1168", "drugName": "RAMIPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01115426"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL846", "drugName": "CALCITRIOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00319761"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 4, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00755859"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1639", "drugName": "ALISKIREN", "type": "Small molecule", "mechanismOfAction": "Renin inhibitor", "actionType": "Inhibitor", "symbol": "REN", "name": "renin", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00870493"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03357653"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL9194", "drugName": "ATRASENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04573478"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4298195", "drugName": "NARSOPLIMAB", "type": "Antibody", "mechanismOfAction": "Mannan-binding lectin serine protease 2 inhibitor", "actionType": "Inhibitor", "symbol": "MASP2", "name": "MBL associated serine protease 2", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03608033"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04578834,https://clinicaltrials.gov/ct2/show/NCT04557462"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201081", "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Not yet recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05510323"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02052219"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01392833,https://clinicaltrials.gov/ct2/show/NCT00657059,https://clinicaltrials.gov/ct2/show/NCT00554502"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1513", "drugName": "IRBESARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1201265", "drugName": "METHYLPREDNISOLONE HEMISUCCINATE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00657059"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Endothelin receptor ET-A antagonist", "actionType": "Antagonist", "symbol": "EDNRA", "name": "endothelin receptor type A", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1542", "drugName": "AZATHIOPRINE", "type": "Small molecule", "mechanismOfAction": "Amidophosphoribosyltransferase inhibitor", "actionType": "Inhibitor", "symbol": "PPAT", "name": "phosphoribosyl pyrophosphate amidotransferase", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00554502,https://clinicaltrials.gov/ct2/show/NCT01392833"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL191", "drugName": "LOSARTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02232776"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL539423", "drugName": "SPARSENTAN", "type": "Small molecule", "mechanismOfAction": "Type-1 angiotensin II receptor antagonist", "actionType": "Antagonist", "symbol": "AGTR1", "name": "angiotensin II receptor type 1", "phase": 3, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03762850"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH1", "name": "inosine monophosphate dehydrogenase 1", "phase": 3, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT00318474"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1200622", "drugName": "PARICALCITOL", "type": "Small molecule", "mechanismOfAction": "Vitamin D receptor agonist", "actionType": "Agonist", "symbol": "VDR", "name": "vitamin D receptor", "phase": 3, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT00599963"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1456", "drugName": "MYCOPHENOLATE MOFETIL", "type": "Small molecule", "mechanismOfAction": "Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor", "actionType": "Inhibitor", "symbol": "IMPDH2", "name": "inosine monophosphate dehydrogenase 2", "phase": 3, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02187900"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL650", "drugName": "METHYLPREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 3, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04833374"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2107877", "drugName": "BLISIBIMOD", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02062684"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13B inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13B", "name": "TNF superfamily member 13b", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594448", "drugName": "IPTACOPAN", "type": "Small molecule", "mechanismOfAction": "Complement factor B inhibitor", "actionType": "Inhibitor", "symbol": "CFB", "name": "complement factor B", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03373461"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL635", "drugName": "PREDNISONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00004448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT02808429"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL393220", "drugName": "ATORVASTATIN CALCIUM", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL131", "drugName": "PREDNISOLONE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Unknown status", "source": "https://clinicaltrials.gov/ct2/show/NCT02662283"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594462", "drugName": "BATIRAXCEPT", "type": "Protein", "mechanismOfAction": "Growth arrest-specific protein 6 inhibitor", "actionType": "Inhibitor", "symbol": "GAS6", "name": "growth arrest specific 6", "phase": 2, "status": "Terminated", "source": "https://clinicaltrials.gov/ct2/show/NCT04042623"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL413", "drugName": "SIROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL269732", "drugName": "TACROLIMUS", "type": "Small molecule", "mechanismOfAction": "FK506-binding protein 1A inhibitor", "actionType": "Inhibitor", "symbol": "FKBP1A", "name": "FKBP prolyl isomerase 1A", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT01224028"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594460", "drugName": "AT-1501", "type": "Unknown", "mechanismOfAction": "CD40 ligand inhibitor", "actionType": "Inhibitor", "symbol": "CD40LG", "name": "CD40 ligand", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05125068"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1742986", "drugName": "ATACICEPT", "type": "Protein", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04716231"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT04287985"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594579", "drugName": "FELZARTAMAB", "type": "Antibody", "mechanismOfAction": "Lymphocyte differentiation antigen CD38 inhibitor", "actionType": "Inhibitor", "symbol": "CD38", "name": "CD38 molecule", "phase": 2, "status": "Recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT05065970"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1487", "drugName": "ATORVASTATIN", "type": "Small molecule", "mechanismOfAction": "HMG-CoA reductase inhibitor", "actionType": "Inhibitor", "symbol": "HMGCR", "name": "3-hydroxy-3-methylglutaryl-CoA reductase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989871", "drugName": "AVACOPAN", "type": "Small molecule", "mechanismOfAction": "C5a anaphylatoxin chemotactic receptor antagonist", "actionType": "Antagonist", "symbol": "C5AR1", "name": "complement C5a receptor 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02384317"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL1370", "drugName": "BUDESONIDE", "type": "Small molecule", "mechanismOfAction": "Glucocorticoid receptor agonist", "actionType": "Agonist", "symbol": "NR3C1", "name": "nuclear receptor subfamily 3 group C member 1", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00767221"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL2103830", "drugName": "FOSTAMATINIB", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT02112838"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL578", "drugName": "ENALAPRIL", "type": "Small molecule", "mechanismOfAction": "Angiotensin-converting enzyme inhibitor", "actionType": "Inhibitor", "symbol": "ACE", "name": "angiotensin I converting enzyme", "phase": 2, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT00396721"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL3989516", "drugName": "FOSTAMATINIB DISODIUM", "type": "Small molecule", "mechanismOfAction": "Tyrosine-protein kinase SYK inhibitor", "actionType": "Inhibitor", "symbol": "SYK", "name": "spleen associated tyrosine kinase", "phase": 2, "status": "Withdrawn", "source": "https://clinicaltrials.gov/ct2/show/NCT02433236"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4297722", "drugName": "CEMDISIRAN", "type": "Oligonucleotide", "mechanismOfAction": "Complement C5 mRNA RNAi inhibitor", "actionType": "Rnai inhibitor", "symbol": "C5", "name": "complement C5", "phase": 2, "status": "Active, not recruiting", "source": "https://clinicaltrials.gov/ct2/show/NCT03841448"}, {"diseaseId": "EFO_0004194", "diseaseName": "IGA glomerulonephritis", "drugId": "CHEMBL4594614", "drugName": "SIBEPRENLIMAB", "type": "Antibody", "mechanismOfAction": "Tumor necrosis factor ligand superfamily member 13 inhibitor", "actionType": "Inhibitor", "symbol": "TNFSF13", "name": "TNF superfamily member 13", "phase": 1, "status": "Completed", "source": "https://clinicaltrials.gov/ct2/show/NCT03719443"}]}}, {"mode": "vega-lite"});
</script></div></div>
</div>
</section>
</section>

    <script type="text/x-thebe-config">
    {
        requestKernel: true,
        binderOptions: {
            repo: "binder-examples/jupyter-stacks-datascience",
            ref: "master",
        },
        codeMirrorConfig: {
            theme: "abcdef",
            mode: "python"
        },
        kernelOptions: {
            name: "python3",
            path: "./step-by-step"
        },
        predefinedOutput: true
    }
    </script>
    <script>kernelName = 'python3'</script>

                </article>
              

              
              
                <footer class="bd-footer-article">
                  
<div class="footer-article-items footer-article__inner">
  
    <div class="footer-article-item"><!-- Previous / next buttons -->
<div class="prev-next-area">
    <a class="left-prev"
       href="step-by-step-altair.html"
       title="previous page">
      <i class="fa-solid fa-angle-left"></i>
      <div class="prev-next-info">
        <p class="prev-next-subtitle">previous</p>
        <p class="prev-next-title">Altair</p>
      </div>
    </a>
    <a class="right-next"
       href="altair-2-scatter-chart.html"
       title="next page">
      <div class="prev-next-info">
        <p class="prev-next-subtitle">next</p>
        <p class="prev-next-title">Scatter Chart</p>
      </div>
      <i class="fa-solid fa-angle-right"></i>
    </a>
</div></div>
  
</div>

                </footer>
              
            </div>
            
            
              
                <div class="bd-sidebar-secondary bd-toc"><div class="sidebar-secondary-items sidebar-secondary__inner">

  <div class="sidebar-secondary-item">
  <div class="page-toc tocsection onthispage">
    <i class="fa-solid fa-list"></i> Contents
  </div>
  <nav class="bd-toc-nav page-toc">
    <ul class="visible nav section-nav flex-column">
<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#">Bar Chart</a><ul class="visible nav section-nav flex-column">
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#playground-data">Playground Data</a></li>
</ul>
</li>
<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#data-viz-as-exploratory-data-analysis">Data Viz as exploratory data analysis</a><ul class="visible nav section-nav flex-column">
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#preview-the-data">Preview the data</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#base-bar-chart">Base Bar Chart</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#adding-a-tooltip">Adding a Tooltip</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#reorder-y-axis-status-by-x-axis-count">Reorder Y-axis (status) by x-axis (count)</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#add-color-encoding">Add Color encoding</a></li>
<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#remove-unnecesary-titles">Remove Unnecesary Titles</a></li>
</ul>
</li>
</ul>

  </nav></div>

</div></div>
              
            
          </div>
          <footer class="bd-footer-content">
            
<div class="bd-footer-content__inner container">
  
  <div class="footer-item">
    
<p class="component-author">
By Jung Hoon Son, M.D.
</p>

  </div>
  
  <div class="footer-item">
    
  <p class="copyright">
    
      © Copyright 2023.
      <br/>
    
  </p>

  </div>
  
  <div class="footer-item">
    
  </div>
  
  <div class="footer-item">
    
  </div>
  
</div>
          </footer>
        

      </main>
    </div>
  </div>
  
  <!-- Scripts loaded after <body> so the DOM is not blocked -->
  <script src="../_static/scripts/bootstrap.js?digest=e353d410970836974a52"></script>
<script src="../_static/scripts/pydata-sphinx-theme.js?digest=e353d410970836974a52"></script>

  <footer class="bd-footer">
  </footer>
  </body>
</html>